MANA Advisors LLC acquired a new stake in ABIOMED, Inc. (NASDAQ:ABMD) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 1,822 shares of the medical equipment provider’s stock, valued at approximately $341,000.
Several other hedge funds also recently modified their holdings of the stock. Retirement Systems of Alabama raised its stake in shares of ABIOMED by 0.3% in the 4th quarter. Retirement Systems of Alabama now owns 77,415 shares of the medical equipment provider’s stock valued at $14,508,000 after acquiring an additional 256 shares in the last quarter. Public Employees Retirement Association of Colorado raised its stake in shares of ABIOMED by 3.0% in the 4th quarter. Public Employees Retirement Association of Colorado now owns 9,028 shares of the medical equipment provider’s stock valued at $1,692,000 after acquiring an additional 261 shares in the last quarter. Sterling Capital Management LLC increased its position in ABIOMED by 2.2% in the 3rd quarter. Sterling Capital Management LLC now owns 13,139 shares of the medical equipment provider’s stock worth $2,215,000 after buying an additional 281 shares during the period. Comerica Bank increased its position in ABIOMED by 0.9% in the 4th quarter. Comerica Bank now owns 33,144 shares of the medical equipment provider’s stock worth $7,721,000 after buying an additional 293 shares during the period. Finally, State of Wisconsin Investment Board increased its position in ABIOMED by 3.6% in the 3rd quarter. State of Wisconsin Investment Board now owns 8,364 shares of the medical equipment provider’s stock worth $1,410,000 after buying an additional 294 shares during the period. 88.42% of the stock is currently owned by institutional investors and hedge funds.
In other news, VP Andrew J. Greenfield sold 20,000 shares of ABIOMED stock in a transaction that occurred on Tuesday, February 20th. The stock was sold at an average price of $270.36, for a total transaction of $5,407,200.00. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 7.00% of the stock is currently owned by company insiders.
ABIOMED, Inc. (ABMD) opened at $294.52 on Monday. ABIOMED, Inc. has a 1 year low of $117.36 and a 1 year high of $297.45. The company has a market capitalization of $13,040.70, a P/E ratio of 153.40, a price-to-earnings-growth ratio of 4.06 and a beta of 0.25.
ABIOMED (NASDAQ:ABMD) last announced its quarterly earnings data on Thursday, February 1st. The medical equipment provider reported $0.70 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.50 by $0.20. ABIOMED had a return on equity of 15.54% and a net margin of 16.58%. The company had revenue of $154.00 million for the quarter, compared to analyst estimates of $154.00 million. During the same quarter last year, the firm earned $0.34 EPS. ABIOMED’s revenue for the quarter was up 34.9% compared to the same quarter last year. equities analysts predict that ABIOMED, Inc. will post 2.3 EPS for the current year.
WARNING: This article was originally posted by Sports Perspectives and is the sole property of of Sports Perspectives. If you are accessing this article on another publication, it was copied illegally and reposted in violation of US and international copyright & trademark laws. The correct version of this article can be viewed at https://sportsperspectives.com/2018/03/12/mana-advisors-llc-acquires-shares-of-1822-abiomed-inc-abmd.html.
ABIOMED, Inc is a provider of temporary percutaneous mechanical circulatory support devices. The Company offers care to heart failure patients. The Company operates in the segment of the research, development and sale of medical devices to assist or replace the pumping function of the failing heart. The Company develops, manufactures and markets products that are designed to enable the heart to rest, heal and recover by improving blood flow to the coronary arteries and end-organs and/or temporarily performing the pumping function of the heart.
Want to see what other hedge funds are holding ABMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ABIOMED, Inc. (NASDAQ:ABMD).
Receive News & Ratings for ABIOMED Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ABIOMED and related companies with MarketBeat.com's FREE daily email newsletter.